Dr. Cavazzoni, I was diagnosed with ALS in December of 2018, I am a slow progressor but no longer eligible to participate in in the phase III. I am not advocating for myself as much as I am for those similar to me that could benefit from AMX0035 and are not eligible when this may be the drug that allows them the life to continue the fight and "live with ALS" I urge you to today make AMX0035 available as you have done for Alzheimer patients with Aduhelm.